4 Leukemia Clinical Trials in Marietta, OH (2026)

Q: How do I join a clinical trial in Marietta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Marietta research site will contact you.

Recruiting Leukemia Studies in Marietta

NCT07361497Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)...

Marietta, OH850 participantsBristol-Myers Squibb

View Study Details

NCT06095583Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

The Study is a Phase 3, randomized, three-arm, double-blind, placebo-controlled, multi-regional clinical research study to evaluate the safety and efficacy use of toripalimab alone or in combination w...

Marietta, OH756 participantsShanghai Junshi Bioscience Co., Ltd.

View Study Details

NCT01804686Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...

Marietta, OH700 participantsJanssen Research & Development, LLC

View Study Details

NCT06646276Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab...

Marietta, OH530 participantsBristol-Myers Squibb

View Study Details

About Leukemia Clinical Trials in Marietta

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Marietta, OH. These studies are seeking a combined 2,836 participants. Research is being sponsored by Bristol-Myers Squibb, Shanghai Junshi Bioscience Co., Ltd., Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Marietta — FAQ

Are there leukemia clinical trials in Marietta?

Yes, there are 4 leukemia clinical trials currently recruiting in Marietta, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Marietta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Marietta research site will contact you about next steps.

Are clinical trials in Marietta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Marietta studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Marietta are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov